Skip to main content

Table 3 Odds ratio and 95% confidence interval for cardiometabolic risk factors: the CASPIAN-V study

From: Are non-high–density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study

Variable

Model

High TC

High LDL

MetS

Low HDL

Overweight

Abdominal obesity

Obesity

High FBS

High TG

High BP

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

Non-HDL-C (mg/dl)

Model I

1.19

(1.17,1.22)*

1.19

(1.17,1.20)*

1.01

(1.00,1.01)*

0.99

(0.99,0.99)*

1.00

(0.99,1.00)

1.00

(0.99,1.00)

1.00

(0.99,1.00)

1.00

(1.00,1.01)

1.03

(1.03,1.03)*

0.99

(0.99,1.00)

Model II

1.19

(1.16,1.22)*

1.19

(1.17,1.21)*

1.01

(1.00, 1.01)*

0.99

(0.99,0.99)*

1.00

(0.99,1.00)

1.00

(0.99,1.00)

1.00

(0.99,1.00)

1.00

(.99,1.01)

1.03

(1.02,1.03)*

0.99

(0.99,1.00)

Model III

1.19

(1.16,1.22)*

1.19

(1.17,1.21)*

1.01

(1.00, 1.01)*

0.99

(0.99,0.99)*

1.00

(.99,1.01)

1.03

(1.02,1.03)*

0.99

(0.99,1.01)

Diff-C (mg/dl)

Model I

1.07

(1.06,1.08)*

1.02

(1.01,1.02)*

1.07 (1.06,1.09)*

1.04

(1.03,1.05)*

1.01

(1.00,1.02)*

1.00

(0.99,1.01)

1.00

(0.99,1.01)

1.04

(1.02,1.05)*

1.02

(1.01,1.02)*

1.00

(0.98,1.01)

Model II

1.07

(1.06,1.09)*

1.02

(1.01,1.03)*

1.08

(1.07,1.01)*

1.04

(1.04,1.05)*

1.01

(1.00,1.02)*

1.00

(0.99,1.01)

1.00

(0.99,1.01)

1.03

(1.02,1.05)*

1.03

(1.02,1.04)*

1.00

(0.99,1.01)

Model III

1.07

(1.06,1.09)*

1.02

(1.01,1.03)*

1.08

(1.07, 1.10)*

1.04

(1.04,1.05)*

1.03

(1.02,1.05)*

1.02

(1.01,1.03)*

1.00

(0.98,1.01)

Atherogenic index

Model I

1.36

(1.26,1.46)*

1.02

(0.96,1.08)

1.8

(1.7, 2.00)*

2.43

(2.25,2.63)*

1.08

(1.00,1.16)*

1.00

(0.95,1.06)

1.03

(0.95,1.10)

1.29

(1.19,1.40)*

38.69

(29.85,50.14)*

1.00

(0.92,1.08)

Model II

1.34

(1.24,1.46)*

1.03

(0.96,1.10)

1.9

(1.7, 2.14)*

2.51

(2.30,2.73)*

1.07

(0.98,1.15)

1.01

(0.95,1.08)

1.03

(0.95,1.12)

1.29

(1.18,1.41)*

40.33

(30.45,53.43)*

1.02

(0.94,1.11)

Model III

1.35

(1.24,1.47)*

1.03

(0.96,1.10)

1.9

(1.8, 2.19)*

2.50

(2.30,2.72)*

1.28

(1.17,1.40)*

40.26

(30.36,53.40)*

1.00

(0.92,1.09)

  1. * Statistically significant, BP blood pressure, TG triglycerides, FBG fasting blood glucose, HDL-C high-density lipoprotein-cholesterol, TC total cholesterol, LDL-C low-density lipoprotein cholesterol;
  2. overweight: BMI; 85th–95th; obesity, BMI > 95th; low HDL: < 40 mg/dL (except in boys 15–19 y old, that cut-off was < 45 mg/dL); high LDL: > 110 mg/dL; high TG: 100 mg/dL; high TC: > 200 mg/dL; elevated FBS > 100 mg/dL; high blood pressure: > 90th (adjusted by age, sex, height); Non–HDL-C concentration was calculated by subtracting HDL-C value from total cholesterol concentration. Diff-C was defined as the difference between total amount of non-HDL cholesterol and LDL-C (Diff-C = [non-HDL-C]-[LDL-C]). Atherogenic index as the ratio between TG and HDL-C concentrations
  3. Model 1: crude model
  4. Model 2: adjusted for age, sex, living area, screen time, SES and physical activity
  5. Model3: additionally adjusted for BMI except for overweight, obesity and abdominal obesity